Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CNR1 | P21554 | 1/20 | 1.00 |
| ▸ | KDM4E | B2RXH2 | 4/20 | 0.89 |
| ▸ | SOAT1 | P35610 | 2/20 | 0.89 |
| ▸ | CYP3A4 | P08684 | 3/20 | 0.78 |
| ▸ | MEN1 | O00255 | 2/20 | 0.78 |
| ▸ | TP53 | P04637 | 2/20 | 0.78 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.78 |
| ▸ | FAAH | O00519 | 1/20 | 0.78 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.78 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.78 |
| ▸ | PPARG | P37231 | 4/20 | 0.72 |
| ▸ | PPARD | Q03181 | 3/20 | 0.72 |
| ▸ | PPARA | Q07869 | 3/20 | 0.72 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.72 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.72 |
| ▸ | LMNA | P02545 | 2/20 | 0.72 |
| ▸ | CYP19A1 | P11511 | 2/20 | 0.72 |
| ▸ | FABP4 | P15090 | 2/20 | 0.72 |
| ▸ | HPGD | P15428 | 2/20 | 0.72 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.72 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Arachidonamide SCHEMBL6667074 | 1.00 | CNR1 (1.00) | CNR1KDM4ESOAT1CYP3A4MEN1 | |
| Arachidonamide SCHEMBL542347 | 1.00 | CNR1 (1.00) | CNR1KDM4ESOAT1CYP3A4MEN1 | |
| Arachidonamide SCHEMBL25341372 | 0.96 | CNR1 (0.93) | CNR1KDM4ESOAT1CYP3A4MEN1 | |
| SCHEMBL4805185 | 0.96 | KDM4E (0.96) | CNR1KDM4ESOAT1CYP3A4MEN1 | |
| SCHEMBL4805179 | 0.96 | KDM4E (0.96) | CNR1KDM4ESOAT1CYP3A4MEN1 | |
| SCHEMBL469455 | 0.96 | KDM4E (0.96) | CNR1KDM4ESOAT1CYP3A4MEN1 | |
| SCHEMBL10445415 | 0.94 | KDM4E (1.00) | CNR1KDM4ESOAT1CYP3A4MEN1 | |
| SCHEMBL571436 | 0.94 | KDM4E (1.00) | CNR1KDM4ESOAT1CYP3A4MEN1 | |
| SCHEMBL469581 | 0.94 | KDM4E (1.00) | CNR1KDM4ESOAT1CYP3A4MEN1 | |
| SCHEMBL7626693 | 0.94 | KDM4E (1.00) | CNR1KDM4ESOAT1CYP3A4MEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 325 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3921150-B1 | THERMOPLASTIC ROOFING MEMBRANES FOR FULLY-ADHERED ROOFING SYSTEMS | HOLCIM TECHNOLOGY LTD (CH) | 2026-05-27 | — | — | EP | claimed |
| US-12503483-B2 | Gemcitabine amphiphile prodrugs | NanoMed Holdings Pty Ltd (AU) | 2025-12-23 | — | — | US | claimed |
| US-12391029-B2 | Thermoplastic roofing membranes for fully-adhered roofing systems | HOLCIM TECHNOLOGY LTD (CH) | 2025-08-19 | — | — | US | claimed |
| US-20250187071-A1 | MULTI-PRINCIPAL ELEMENT ALLOY (MPEA) NANOPARTICLES | THE JOHNS HOPKINS UNIVERSITY | 2025-06-12 | — | — | US | claimed |
| CN-119799338-A | Silicon wafer cleaning etching solution and application thereof in inhibiting surface oxidation of silicon wafer | 湖北兴福电子材料股份有限公司 | 2025-04-11 | — | — | CN | claimed |
| CN-119546525-A | Composition and method for producing the same | 博里利斯股份公司 | 2025-02-28 | — | — | CN | claimed |
| US-20240300230-A1 | THERMOPLASTIC ROOFING MEMBRANES FOR FULLY-ADHERED ROOFING SYSTEMS | AMRIZE TECHNOLOGY SWITZERLAND LLC (CH) | 2024-09-12 | — | — | US | claimed |
| US-11987025-B2 | Thermoplastic roofing membranes for fully-adhered roofing systems | HOLCIM TECHNOLOGY LTD (CH) | 2024-05-21 | — | — | US | claimed |
| CN-118043040-A | Arachidonic acid ethanolamine cyclodextrin inclusion complex carrier | 西泽普研究与发展有限责任公司 | 2024-05-14 | — | — | CN | claimed |
| WO-2024040088-A1 | MULTI-PRINCIPAL ELEMENT ALLOY (MPEA) NANOPARTICLES | THE JOHNS HOPKINS UNIVERSITY (US) | 2024-02-22 | — | — | WO | claimed |
| WO-2021043785-A1 | A PIPE CONTAINING CARBOXYLIC ACID AMIDE FOR THE TRANSPORT OF WATER CONTAINING CHLORINATED DISINFECTANT | SABIC GLOBAL TECHNOLOGIES B.V. (NL) | 2021-03-11 | — | — | WO | claimed |
| EP-3784681-A1 | GEMCITABINE AMPHIPHILE PRODRUGS | NanoMed Holdings Pty Ltd (AU) | 2021-03-03 | — | — | EP | claimed |
| US-9480752-B2 | Anandamide-modified nucleic acid molecules | BASECLICK GMBH (DE) | 2016-11-01 | — | — | US | claimed |
| CN-105793247-A | Imidazolecarboxamides and their use as FAAH inhibitors | 比亚尔-珀特拉和CA股份公司 | 2016-07-20 | — | — | CN | claimed |
| EP-1636335-B1 | COMPOSITIONS AND METHODS FOR INHIBITING AN ISOFORM OF HUMAN MANGANESE SUPEROXIDE DISMUTASE | MITO TEK LLC (US) | 2012-07-11 | — | — | EP | claimed |
| US-8084527-B2 | Hotmelt adhesive with good adhesion to polyolefins | SIKA TECHNOLOGY AG (CH) | 2011-12-27 | — | — | US | claimed |
| EP-2075297-B1 | Hot melt adhesive with good adhesion to polyolefines | SIKA TECHNOLOGY AG (CH) | 2010-02-24 | — | — | EP | claimed |
| US-20090142610-A1 | Hotmelt adhesive with good adhesion to polyolefins | SIKA TECHNOLOGY AG (CH) | 2009-06-04 | — | — | US | claimed |
| US-6521249-B2 | Effects of dietary cation-anion difference (DCAD) and essential fatty acid nutrients on calcium homeostasis in prepartum dairy cattle (hypocalcemia) | CHURCH & DWIGHT CO., INC. | 2003-02-18 | — | — | US | claimed |
| US-5631297-A | MIXTURES WITH CYCLODEXTRIN | PATE DAVID W (NL) | 1997-05-20 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12503483-B2 | Gemcitabine amphiphile prodrugs | GBA1, GMNN, TYMP | CNR1 1523/4885KDM4E 4284/4885SOAT1 2101/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.